Ligand validation:6LZN

ILE: ISOLEUCINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LZN_ILE_A_1407	73%	29%	0.095	0.942	1.08	1.72	-	2	0	0	89%	0.8889
6SEL_ILE_A_402	81%	52%	0.105	0.977	0.62	1.23	-	-	0	0	89%	0.8889
2WHZ_ILE_A_1001	76%	46%	0.099	0.954	0.71	1.34	-	1	0	0	89%	0.8889
8ZM6_ILE_A_401	66%	36%	0.116	0.941	1.1	1.41	-	1	0	0	89%	0.8889
8ZM5_ILE_A_401	64%	31%	0.121	0.94	1.25	1.5	1	2	1	0	89%	0.8889
8ZM4_ILE_A_1406	64%	23%	0.127	0.945	1.43	1.71	2	2	0	0	89%	0.8889
4OAT_ILE_A_501	99%	52%	0.052	0.984	0.82	1.04	-	-	0	0	100%	1
2ZBC_ILE_A_85	97%	35%	0.054	0.966	1.57	1	2	-	0	0	100%	1
5N0L_ILE_C_201	96%	58%	0.067	0.978	0.86	0.77	-	-	1	0	100%	1
4GNR_ILE_A_401	94%	30%	0.085	0.984	1.79	1.04	1	-	0	0	100%	1
3B3T_ILE_A_299	93%	73%	0.074	0.968	0.62	0.44	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.